Clozapine Monitoring: New Guidelines for the Post-REMS Era
In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable clozapine continue lifelong monthly blood draws, or can we safely reduce monitoring after two years? Dr. Seeber discusses how these evidence-based recommendations balance patient burden with safety. Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 79 New Guidelines for Clozapine ANC Monitoring
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Psychopharmacology and Psychiatry Updates
Could Lithium Play a Role in Preventing Alzheimer's Disease?
Managing ADHD in Pregnancy: Weighing Risk versus Risk
Ondansetron for Negative Symptoms of Schizophrenia
Managing SSRIs During Pregnancy: Myths vs. Evidence
Get summaries like this every morning.
Free AI-powered recaps of Psychopharmacology and Psychiatry Updates and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.